ResearcherPrinceton UniversityNo recent work listed
Jurre J. Kamphorst
Matched on ORCID iD 0000-0002-2042-5474; OpenAlex author ID A5033187116. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2015: 2 papers · 2016: none · 2017: 1 paper · 2018: 1 paper
Papers 4
- Rho Kinase Inhibition by AT13148 Blocks Pancreatic Ductal Adenocarcinoma Invasion and Tumor Growth. Co-author DOI 10.1158/0008-5472.can-17-1339↗
- Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin. Co-author DOI 10.1158/1078-0432.ccr-17-1115↗
- Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Co-author DOI 10.1158/0008-5472.can-14-2211↗
- Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function. Co-author DOI 10.1158/0008-5472.can-15-0108↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Joshua D. Rabinowitz · 3 shared papers, 2015–2017 · strength 0.15
- Paper Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin. DOI 10.1158/1078-0432.ccr-17-1115↗
- Paper Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. DOI 10.1158/0008-5472.can-14-2211↗
- Paper Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function. DOI 10.1158/0008-5472.can-15-0108↗
- Shinichi Yabuuchi · 2 shared papers, 2015–2017 · strength 0.11
- Paper Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin. DOI 10.1158/1078-0432.ccr-17-1115↗
- Paper Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function. DOI 10.1158/0008-5472.can-15-0108↗
- N.V. Rajeshkumar · 2 shared papers, 2015–2017 · strength 0.11
- Paper Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin. DOI 10.1158/1078-0432.ccr-17-1115↗
- Paper Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function. DOI 10.1158/0008-5472.can-15-0108↗
- Manuel M. Hidalgo · 2 shared papers, 2015–2017 · strength 0.11
- Paper Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin. DOI 10.1158/1078-0432.ccr-17-1115↗
- Paper Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function. DOI 10.1158/0008-5472.can-15-0108↗
- Anirban Maitra · 2 shared papers, 2015–2017 · strength 0.11
- Paper Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin. DOI 10.1158/1078-0432.ccr-17-1115↗
- Paper Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function. DOI 10.1158/0008-5472.can-15-0108↗
- Chi Van Dang · 2 shared papers, 2015–2017 · strength 0.11
- Paper Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin. DOI 10.1158/1078-0432.ccr-17-1115↗
- Paper Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function. DOI 10.1158/0008-5472.can-15-0108↗
- Evdokia Michalopoulou · 1 shared paper, 2018 · strength 0.07
- Claire Vennin · 1 shared paper, 2018 · strength 0.07
- Nicola Rath · 1 shared paper, 2018 · strength 0.07
- Marina Pajic · 1 shared paper, 2018 · strength 0.07
- Paul Timpson · 1 shared paper, 2018 · strength 0.07
- Michael F. Olson · 1 shared paper, 2018 · strength 0.07
- Wenyun Lu · 1 shared paper, 2015 · strength 0.05
- Michel Nofal · 1 shared paper, 2015 · strength 0.05
- Craig B Thompson · 1 shared paper, 2015 · strength 0.05
- Dafna Bar‐Sagi · 1 shared paper, 2015 · strength 0.05
- Elda Grabocka · 1 shared paper, 2015 · strength 0.05
- Jeffrey A. Drebin · 1 shared paper, 2015 · strength 0.05
- Cosimo Commisso · 1 shared paper, 2015 · strength 0.05
- Matthew G. Vander Heiden · 1 shared paper, 2015 · strength 0.05
- George Miller · 1 shared paper, 2015 · strength 0.05
- Anne Le · 1 shared paper, 2015 · strength 0.04
- Robert J. Gillies · 1 shared paper, 2015 · strength 0.04
- Prasanta Dutta · 1 shared paper, 2015 · strength 0.04
- Roeland F. de Wilde · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.